These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22138434)

  • 41. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant.
    Justinova Z; Munzar P; Panlilio LV; Yasar S; Redhi GH; Tanda G; Goldberg SR
    Neuropsychopharmacology; 2008 Nov; 33(12):2870-7. PubMed ID: 18305459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
    Vivian JA; Kishioka S; Butelman ER; Broadbear J; Lee KO; Woods JH
    J Pharmacol Exp Ther; 1998 Aug; 286(2):697-703. PubMed ID: 9694923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.
    Docherty JR; Green AR
    Br J Pharmacol; 2010 Jul; 160(5):1029-44. PubMed ID: 20590597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
    Rodsiri R; Spicer C; Green AR; Marsden CA; Fone KC
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):365-76. PubMed ID: 20645080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
    Parrott AC; Milani RM; Gouzoulis-Mayfrank E; Daumann J
    J Neural Transm (Vienna); 2007; 114(8):959-68. PubMed ID: 17520319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats.
    Lopez-Rodriguez AB; Llorente-Berzal A; Garcia-Segura LM; Viveros MP
    Br J Pharmacol; 2014 Mar; 171(6):1435-47. PubMed ID: 24236988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys.
    Nakamura-Palacios EM; Winsauer PJ; Moerschbaecher JM
    Behav Pharmacol; 2000 Aug; 11(5):377-86. PubMed ID: 11103889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.
    Hayakawa K; Mishima K; Abe K; Hasebe N; Takamatsu F; Yasuda H; Ikeda T; Inui K; Egashira N; Iwasaki K; Fujiwara M
    Neuroreport; 2004 Oct; 15(15):2381-5. PubMed ID: 15640760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; Li C; Vadivel SK; Makriyannis A
    Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.
    Llorente-Berzal A; Puighermanal E; Burokas A; Ozaita A; Maldonado R; Marco EM; Viveros MP
    PLoS One; 2013; 8(11):e78386. PubMed ID: 24223797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
    Hayakawa K; Mishima K; Nozako M; Ogata A; Hazekawa M; Liu AX; Fujioka M; Abe K; Hasebe N; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2007 Mar; 52(4):1079-87. PubMed ID: 17320118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.
    Schindler CW; Gramling BR; Justinova Z; Thorndike EB; Baumann MH
    Drug Alcohol Depend; 2017 Oct; 179():387-394. PubMed ID: 28846955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
    Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
    Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
    Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
    Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH; Fisher J; Martin BR
    Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
    Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
    Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.